Kim Forest revenue doubled last monthCOVID-19 TESTING: A spokesman said that the firm can analyze up to 10,000 samples a day, while the maximum number of samples collected in Taipei daily is about 2,000By Kao Shih-ching / Staff reporterKim Forest Enterprise Co (金萬林), which focuses on molecular testing, yesterday reported that revenue last month doubled from a year earlier to a record NT$54.04 million (US$1.95 million) as domestic demand for COVID-19 testing rose amid an outbreak in Taiwan. Photo courtesy of Chi Mei Medical CenterAs Kim Forest produces test kits for SARS-CoV-2 — which causes COVID-19 — supplies its own PCR machines and is an agent for foreign-made PCR machines, its labs have ample capacity to facilitate testing, he said. Although the lab entity is not a company, Kim Forest owns it, so could still recognize the revenue into its consolidated figures, he said. “The revenue structure is different from last year, when the main source of revenue was overseas sales of PCR machines,” Yang said. In the first five months of this year, Kim Forest’s cumulative revenue grew 76.43 percent annually to NT$164 million, company data showed.

Source: Taipei Times June 15, 2021 15:56 UTC